Trial Profile
Functional Neuroimaging (fMRI) Biomarker of Allosteric Nicotinic Receptor Modulation in Mild Alzheimer's Disease Patients: A Razadyne vs. Aricept Dose Escalation Trial
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 15 Apr 2013
Price :
$35
*
At a glance
- Drugs Donepezil (Primary) ; Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- 06 Jun 2008 Status changed from recruiting to discontinued.
- 02 Feb 2007 Status changed from planning to recruiting.
- 29 Oct 2006 New trial record.